Cipla appeals against Onbrez decision

16-01-2015

Cipla appeals against Onbrez decision

lucarista / Shutterstock.com

Cipla has appealed against a decision by the Delhi High Court that blocked the generic drug maker from marketing copies of Novartis’s respiratory drug Onbrez (indacaterol) in India.


patent infringement, Cipla, Onbrez, Novartis, Delhi High Court

LSIPR